The Patent Finder

Alize Pharma SAS

Also on record
Records under this name other than patents Alize Pharma SAS holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 8 of 8 · Back to Alize Pharma SAS

PatentTitleStatus Expires Confidence
US 8,222,217Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders
Lapsed on the fee record
Ended Jul 17, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jul 17, 2024From the USPTO record
US 8,071,368Methods for promoting growth and survival of insulin-secreting cells
Term ended
Term ended Jan 28, 2023 · From the USPTO record
Term endedTerm ended Jan 28, 2023From the USPTO record
US 7,825,090Use of ghrelin and unacylated ghrelin compositions for treating insulin resistance
Lapsed on the fee record
Ended Nov 2, 2022 · From the USPTO record
Lapsed on the fee recordEnded Nov 2, 2022From the USPTO record
US 7,666,833Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
Lapsed on the fee record
Ended Feb 23, 2022 · From the USPTO record
Lapsed on the fee recordEnded Feb 23, 2022From the USPTO record
US 8,476,408Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease
Lapsed on the fee record
Ended Jul 2, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jul 2, 2021From the USPTO record
US 7,485,620Pharmaceutical Compositions Comprising Unacylated Ghrelin and Therapeutical Uses Thereof
Lapsed on the fee record
Ended Feb 3, 2021 · High confidence
Lapsed on the fee recordEnded Feb 3, 2021High confidence
US 9,550,821Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin
Lapsed on the fee record
Ended Jan 24, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jan 24, 2021From the USPTO record
US 8,318,664Unacylated ghrelin fragments as therapeutic agent in the treatment of obesity
Lapsed on the fee record
Ended Nov 27, 2020 · From the USPTO record
Lapsed on the fee recordEnded Nov 27, 2020From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited